Loading chat...
NY S02489
Bill
Status
6/15/2017
Primary Sponsor
Kemp Hannon
Click for details
AI Summary
-
Allows pharmacists to substitute brand name epinephrine auto-injectors with alternate epinephrine auto-injectors containing the same active ingredients, dosage form, and strength without requiring the product to be on the official interchangeable drug products list.
-
Substitution requires three conditions: the prescriber does not mark the prescription "dispense as written," the alternate product has a lower unit cost, and the pharmacist obtains the patient's informed consent.
-
Defines "epinephrine auto-injector" by reference to the definition in Public Health Law section 3000-c.
-
Takes effect immediately upon enactment.
Legislative Description
Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors in certain cases.
Last Action
COMMITTED TO RULES
6/20/2018